154 related articles for article (PubMed ID: 18521482)
1. Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region.
Ayad NM; Fattah WA; Bakry H
Saudi Med J; 2008 Jun; 29(6):919-20. PubMed ID: 18521482
[No Abstract] [Full Text] [Related]
2. Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia.
Ali M; White J; Lee CH; Palmer JL; Smith-Palmer J; Fakhoury W; Valentine WJ
J Med Econ; 2008; 11(4):651-70. PubMed ID: 19450074
[TBL] [Abstract][Full Text] [Related]
3. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
[TBL] [Abstract][Full Text] [Related]
4. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
5. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
Spellman CW
J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
[TBL] [Abstract][Full Text] [Related]
6. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
8. A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes.
Meneilly GS
Diabetes Obes Metab; 2007 Sep; 9(5):754-5. PubMed ID: 17697065
[TBL] [Abstract][Full Text] [Related]
9. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
[No Abstract] [Full Text] [Related]
10. [Biphasic analog insulin instead of mixed insulin. Better adjustment, less hypoglycemia].
MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866308
[No Abstract] [Full Text] [Related]
11. Starting insulin therapy in type 2 diabetes: lesson 2.
McCall AL
Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
[No Abstract] [Full Text] [Related]
12. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hypoglycemia in a patient receiving insulin detemir.
Olson RP; Bethel MA; Lien L
Anesth Analg; 2009 Jun; 108(6):1836-8. PubMed ID: 19448209
[TBL] [Abstract][Full Text] [Related]
14. The evidence for achieving glycemic control with incretin mimetics.
Drucker DJ
Diabetes Educ; 2006; 32 Suppl 2():72S-81S. PubMed ID: 16554431
[No Abstract] [Full Text] [Related]
15. Biphasic insulin treatment in type 2 diabetes patients.
Pitocco D; Zaccardi F
Acta Biomed; 2010 Sep; 81(2):85-6. PubMed ID: 21309129
[No Abstract] [Full Text] [Related]
16. The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes.
Krones R; Schütte C; Heise T
Diabetes Obes Metab; 2009 Jan; 11(1):41-4. PubMed ID: 19120432
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control for organs: a new approach to a controversial topic.
Nunnally ME; O'Connor MF
Anesthesiology; 2009 Feb; 110(2):207-8. PubMed ID: 19194143
[No Abstract] [Full Text] [Related]
18. Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients.
De Feyter HM; Praet SF; van den Broek NM; Kuipers H; Stehouwer CD; Nicolay K; Prompers JJ; van Loon LJ
Diabetes Care; 2007 Oct; 30(10):2511-3. PubMed ID: 17626892
[No Abstract] [Full Text] [Related]
19. Achieving glycemic goals in type 2 diabetes.
Bloomgarden ZT
Diabetes Care; 2007 Jan; 30(1):174-80. PubMed ID: 17192357
[No Abstract] [Full Text] [Related]
20. Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
Yang WY; Ji QH; Zhu DL; Yang JK; Chen LL; Liu ZM; Yu DM; Yan L
Chin Med J (Engl); 2009 Jul; 122(14):1704-8. PubMed ID: 19719975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
